Stock EOLS EVOLUS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Evolus, Inc.

Equities

EOLS

US30052C1071

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
12.75 USD -2.89% Intraday chart for Evolus, Inc. -4.14% +21.08%
May. 07 Evolus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Transcript : Evolus, Inc., Q1 2024 Earnings Call, May 07, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Certain Options of Evolus, Inc. are subject to a Lock-Up Agreement Ending on 11-MAY-2024.
CI
Certain Common Stock of Evolus, Inc. are subject to a Lock-Up Agreement Ending on 11-MAY-2024.
CI
Certain Restricted Stock Units of Evolus, Inc. are subject to a Lock-Up Agreement Ending on 11-MAY-2024.
CI
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
BU
Evolus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Evolus, Inc., Q1 2024 Earnings Call, May 07, 2024
Evolus Reports First Quarter 2024 Results and Provides Business Update
BU
Earnings Flash (EOLS) EVOLUS Reports Q1 Revenue $59.3M, vs. Street Est of $57.3M
MT
Evolus, Inc. Reaffirms Financial Guidance for the Full Year 2024
CI
AbbVie raises annual profit forecast on strong Skyrizi sales
RE
Evolus to Report First Quarter Financial Results on May 7, 2024
BU
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
BU
Evolus, Inc. Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra- Strength" 40U Formulation of Jeuveau
CI
Evolus Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Evolus, Inc. Announces Board Changes
CI
Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
BU
Evolus Insider Sold Shares Worth $1,344,604, According to a Recent SEC Filing
MT
Transcript : Evolus, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:00 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EOLS Stock
  4. News Evolus, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW